Cargando...
Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
Parkinson’s disease (PD) is the second most common neurodegenerative disorder of the elderly, presenting primarily with symptoms of motor impairment. The disease is diagnosed most commonly by clinical examination with a great degree of accuracy in specialized centers. However, in some cases, non-cla...
Gardado en:
| Publicado en: | Front Aging Neurosci |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8298029/ https://ncbi.nlm.nih.gov/pubmed/34305577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2021.702639 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|